Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients

Transplantation

Volumn 61, Issue 2, 1996, Pages 285-291

  Rukavina, Daniel ^a   Balen Marunic, Sanja ^a   Rubesa, Gordana ^a   Orlic, Petar ^a   Vujaklija, Ksenija ^a   Podack, Eckhard R ^b  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; KILLER CELL; LYMPHOCYTE SUBPOPULATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECIPIENT;

BIOLOGICAL MARKERS; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030057023     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601270-00021     Document Type: Article

References (42)

1. Podack ER. Lymphocyte mediated cytotoxicity. In Preissner KT, Rosenblat S, Kost C, Wegorhoff J, Mosher DF, eds. Biology of vitronectins and their receptors. Amsterdam: Elsevier, 1993: 237.
2. Podack ER. Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr Opin Immunol 1995; 7: 11.
3. Kagi D, Lederman B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin deficient mice. Nature 1994; 369: 31.
4. +-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177: 195.
5. Yonehara S, Ishii Al, Yonehara M. A cell-killing monoclonal antibody (Anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747.
6. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169.
7. Doherty PC. Cell mediated cytotoxicity. Cell 1993; 75: 607.
8. Zheng LM, Ojcius DM, Young JD-E. Distribution of perforin-containing cells in normal and pregnant mice. Eur J Immunol 1993; 23: 2085.
9. Liu PI, Joag SV, Young JD-E, Chang YS, Soong YK, Kuo TT. Expression of perforin by natural killer cells within first trimester endometrium in humans. Biol Reprod 1991; 45: 698.
10. Rukavina D, Rubesa G, Gudelj L, Haller H, Podack ER. Characteristics of perforin expressing lymphocytes within the first trimester decidua of human pregnancy. Am J Reprod Immunol 1995; 33: 394.
11. Muller C, Kagi D, Aebischer T, et al. Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol 1989; 19: 1253.
12. + lymphocytes in autoimmune disease. J Immunol 1989; 143: 3994.
13. Kataoka K, Naomoto Y, Shiozaki S, et al. Infiltration of perforin-positive mononuclear cells into the rejected kidney allograft. Transplantation 1991; 53: 240.
14. Matsuno T, Sakagami K, Saito S, Naomoto Y, Okumura K, Orita K. Does perforin mediate the direct injury of renal allografts in acute rejection? Transplant Proc 1993; 25: 879.
15. Hal BM. Cellular infiltrates in allografts. Transpl Proc 1987; 19: 50.
16. Pfeffer PF, Gjertsen HA, Gandersnack G, Lexow PB, Sodal G, Thorsby E. Analysis of infiltrating lymphocytes from FNAB in kidney transplant patients by a rapid and sensitive immunomagnetic method. Transplant Proc 1989; 21: 354.
17. Raftery MJ, Seron D, Harley B, Koffman G, Cameron JS. Immunohistological analysis of the early renal allograft biopsy. Transplant Proc 1989; 21: 280.
18. Totterman TH, Hanas E, Larsson E, Sjoberg G, Tufveson G. Regulation of human allograft rejection: kidney-infiltrating suppressor inducer and suppressor effector T-cells are reduced during rejection. Transplant Proc 1989; 21: 359.
19. Tilney NL, Kupiec-Weglinski JW. Advances in understanding of rejection mechanisms. Transplant Proc 1989; 21: 10.
20. Solillou JP, Moreau JF. NK cell activity in allograft immunity. J Heart Transplant 1982; 2: 52.
21. + (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants. Transplantation 1985; 39: 25.
22. Legendre CM, Guttman RD, Hou SK, Jean R. Two colour immunofluorescence and flow cytometry analysis of lymphocytes in long-term renal allograft recipients: identification of a major Leu-7+/Leu3+ subpopulation. J Immunol 1985; 135: 1061.
23. Trinchieri G, Perussia B. Human NK cells, biologic and pathologic aspects. Lab Invest 1984; 50: 489.
24. Legendre CM, Guttman RD, Yip GH. NK cell subsets in long-term renal allograft recipients: a phenotypic and functional study. Transplantation 1986; 42: 347.
25. Yagita H, Nakata M, Kawasaki A, Shinkai Z, Okumura K. The role of perforin in lymphocyte mediated cytolysis. Adv Immunol 1992; 51: 215.
26. Rukavina D, Rubesa G, Gudelj L, Podack ER. The human decidual lymphocytes: phenotype, perforin expression and function. Reg Immunol 1994; 6: 320.
27. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991; 12: 415.
28. Sumner H, Abraham D, Bon-Gharios G, Plater-Zyberk C, Olsen J. Simultaneous measurement of cell surface and intracellular antigens by multiple flow cytometry. J Immunol Methods 1991; 136: 259.
29. Bugeon L, Cuturi M-C, Paineau J, Anegon I, Soulillou JP. Similar levels of granzyme A and perforin mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 1993; 56: 405.
30. Griffiths GM, Namikawa R, Mueller C, et al. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol 1991; 21: 687.
31. Clement MV, Legros-Maida S, Israel-Biet D, et al. Perforin and granzyme B expression is associated with severe acute rejection. Transplantation 1994; 57: 322.
32. Mueller C, Shao Y, Altermatt HJ, Hess MW, Shelby J. The effect of cyclosporin treatment on the expression of genes encoding granzyme A and perforin in the infiltrate of mouse heart transplants. Transplantation 1993; 55: 139.
33. McWhinnie DL, Carter NP, Tayor HM, Chapman JR, Wood RFM, Morris PJ. Is the T4/T8 ratio an irrelevance in renal transplantation monitoring? Transplant Proc 1985; 17: 2548.
34. Waltzer WC, Miller F, Arnold A, Anaise D, Rapaport F. Immunohistologic analysis of human renal allograft dysfunction. Transplantation 1987; 43: 100.
35. Weintraub D, Masek M, Billingham ME. The lymphocyte subpopulations in cyclosporin-treated human heart rejection. J Heart Transplant 1985; 4: 213.
36. Nagler A, Lanier L, Cwirla S, Phillips JH. Comparative studies of human FcR III-positive and negative natural killer cells. J Immunol 1989; 143: 3183.
37. Abrams SI, Brahmi Z. Target cell directed NK inactivation: concomitant loss of NK and antibody-dependent cellular cytotoxicity activities. J Immunol 1988; 140: 2090.
38. Hayes MP, Berrebi GA, Henkart PA. Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 1989; 170: 933.
39. Sunders-Plassmann G, Wagner L, Hruby K, Balcke P, Worman CP. Upregulation of a lymphoid serine protease in kidney allograft recipients. Kidney Int 1990; 37: 1350.
40. Mueller C, Gershenfeld HK, Lobo CG, Okada CY, Bleaskley RC, Weissman IL. A high proportion of T lymphocytes that infiltrate H-2 incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases but do not express the MEL-14-defined lymph node homing receptor. J Exp Med 1988; 167: 1124.
41. Liu CC, Rafili S, Granelli-Piperno A, Traapani JA, Young JD-E. Perforin and serine esterase gene expression in stimulated human T cells. J Exp Med 1989; 170: 2105.
42. Ping L, Garcia-Sanz JA, Lichtenheld MG, Podack ER. Perforin expression in human peripheral blood mononuclear cells. J Immunol 1992; 148: 3354.